Nelson Vergel
Founder, ExcelMale.com
Curated by Nelson Vergel | ExcelMale.com | Updated May 2025
You started testosterone therapy to feel better. More energy, clearer thinking, stronger in the gym. It worked. But at some point, the question of fatherhood comes up, and you discover that TRT has been quietly doing something you weren't told about: it has likely shut off your sperm production entirely.
This is one of the most common and consequential gaps in TRT counseling. According to a survey of specialists from the Society for the Study of Male Reproduction (SSMR), nearly 46% of men starting TRT had no idea the therapy could render them infertile. For men who decide they want children, this moment of discovery is a crisis. The good news is that restoring, and often preserving, sperm production is possible with targeted therapy. The primary tool is human chorionic gonadotropin (HCG).
This guide explains exactly how TRT suppresses your reproductive system, how HCG counteracts that suppression, what the clinical data actually shows about recovery timelines, and how to interpret blood work that may be telling you the wrong story.
• Luteinizing Hormone (LH): tells the Leydig cells in the testes to produce testosterone.
• Follicle Stimulating Hormone (FSH): tells the Sertoli cells to initiate and sustain spermatogenesis.
When you inject or apply exogenous testosterone, your brain detects elevated circulating levels and applies the brakes on the entire axis. The hypothalamus reduces GnRH output. The pituitary stops releasing LH and FSH. Without LH signaling, the testes' Leydig cells stop producing intratesticular testosterone (ITT), the high-concentration testosterone inside the testicular tissue itself that drives sperm maturation. ITT can be 50 to 100 times higher than serum testosterone under normal conditions. When exogenous testosterone replaces that signal, ITT can drop by up to 94% from baseline.
Without adequate ITT and FSH, the spermatogenic machinery stalls. Studies show that clinical azoospermia (zero sperm in ejaculate) can develop within 10 weeks of starting TRT at doses of 100-200 mg per week. One landmark WHO study found that after 6 months of 200 mg/week testosterone enanthate, 65% of men were fully azoospermic, with the remainder severely oligospermic. Up to 10% of men may remain azoospermic for an extended period even after stopping TRT, without intervention.
Think of HCG as a bypass cable that connects power directly to the engine when the ignition switch is off. The pituitary may be quiet, but the testes receive the signal they need to keep running.
The striking finding: at every time point, roughly half of men on HCG still had suppressed LH and FSH below the 1.5 mIU/mL recovery threshold. By the traditional interpretation, these men should not be producing viable sperm. But that is not what semen analysis showed.
At 3 months, there was no meaningful difference between groups. At 6 months, the suppressed FSH group actually had higher average sperm counts than the recovered group. These results carry a clear clinical message: when managing TRT-induced infertility, semen analysis is a more reliable guide than serum gonadotropins. Do not delay fertility decisions because FSH has not crossed a lab threshold.
A multivariate regression confirmed that HCG use was the only statistically significant predictor of higher sperm counts (p < 0.0001). Patient age and duration of prior TRT were not significant factors. This is reassuring: the protective effect of prophylactic HCG holds regardless of how old you are or how long you have been on testosterone, as long as HCG is started alongside TRT.
In 42 men with TRT-induced azoospermia (median 19.5 months on TRT), combination therapy (HCG + clomiphene, n = 33) was compared to HCG monotherapy alone (n = 9):
The difference in sperm output between the two regimens was not statistically significant. Adding clomiphene produced a non-significant trend toward better FSH normalization but did not meaningfully increase the number of motile sperm produced. Given that FSH normalization does not correlate reliably with sperm count anyway, this finding reinforces HCG monotherapy as a rational, sufficient, and more cost-effective first-line approach for most men.
A 2024 study in Fertility and Sterility using a 3,000 IU hCG + 75 IU FSH three-times-weekly protocol in 77 men showed that 74% improved sperm concentration. Importantly, men who stayed on testosterone therapy during the recovery protocol had identical recovery rates (74%) to those who stopped TRT, suggesting that you may not always need to discontinue testosterone to restore fertility.
• First 1-3 months: Most men see initial sperm return. In Kannady et al., 89% of men demonstrated the return of spermatogenesis within the first 3 months of HCG treatment. Average time to first semen analysis showing sperm was 4.6 months.
• 3-6 months: Parameters continue to improve. Some men with prolonged suppression or older age take longer to optimize counts and motility.
• 6-12 months: Men on TRT for more than one year, or those over age 60, may require up to 12 months or longer. Approximately 56% of specialists consider recovery unlikely after more than one year of TRT, though recent data challenges this pessimism.
• Persistent azoospermia: Up to 10-20% of men do not recover normal spermatogenesis without pharmacological support, even after stopping TRT.
The ExcelMale community has documented many men who successfully restored fertility after years on TRT, in some cases while staying on testosterone throughout the process. The ExcelMale thread on improving sperm quality, LH, FSH and testosterone in infertile men includes first-hand accounts from men who achieved pregnancy without ever stopping TRT, using combined HCG and FSH protocols.
Dose escalation is commonly used. In the SSMR survey, 76% of providers reported escalating HCG dose when initial response was insufficient. The need for dose adjustment underscores the importance of serial semen analysis rather than relying solely on lab work to guide decisions.
• Insurance coverage: 80% of SSMR specialists report that insurance rarely covers HCG fertility treatments. For men paying out of pocket, a 2,000 IU three-times-weekly protocol can be a significant ongoing expense.
• Provider knowledge gaps: Many primary care physicians and even some TRT prescribers are not adequately informed about fertility preservation. Some men have been told HCG is only cosmetic. This is incorrect.
• Lack of standardized guidelines: There is currently no published consensus protocol from major urology or endocrinology societies for TRT-induced infertility beyond the broad recommendation to stop TRT. Dosing, timing, and monitoring decisions vary widely by provider.
• Delayed counseling: With 46% of men starting TRT unaware of fertility risk, many do not begin preservation strategies in time. Sperm banking before starting TRT is an option that is underutilized.
If you are facing insurance denials, the ExcelMale forum has threads discussing compounding pharmacy options for HCG and strategies for working with fertility specialists who understand TRT-related cases.
• Why use HCG with TRT? A clinical review covering HPG mechanisms and dosing evidence
• Best HCG dose for men on TRT: landmark studies reviewed
• HCG dose and frequency for fertility and testicular atrophy prevention
• HCG dosage strategies for TRT optimization
• Recovery of sperm production following testosterone replacement or anabolic steroids
• Testosterone as a contraceptive: what men who want fertility need to know
• How long before LH and FSH shut down after starting testosterone?
• Fertility maintenance or restoration in men before, during, and after TRT or AAS
• Improving sperm quality, LH, FSH and testosterone in infertile men: community experiences
2. Fertility and Sterility. Optimal Restoration of Spermatogenesis After Testosterone Therapy Using HCG and FSH. 2024. Link
3. Hochu G, Geyer-Kim I, Kim E. Preserving Spermatogenesis in Testosterone Deficiency: Innovations in Replacement and Stimulatory Therapies. Translational Andrology and Urology. 2025. Link
4. PMC. Clinician's Guide to Management of Azoospermia Induced by Exogenous Testosterone or AAS. 2025. Link
5. McBride JA, Coward RM. Recovery of Spermatogenesis Following Testosterone Replacement Therapy or Anabolic-Androgenic Steroid Use. Asian Journal of Andrology. 2016. Link
6. Kohn TP, et al. Fertility Outcomes After Testosterone Replacement Therapy or Anabolic Steroid Abuse. Journal of Urology. 2018. Link
7. Hsieh TC, et al. Concomitant Intramuscular Human Chorionic Gonadotropin Preserves Spermatogenesis in Men Undergoing Testosterone Replacement Therapy. Journal of Urology. 2013. Link
8. Coviello AD, et al. Low-Dose Human Chorionic Gonadotropin Maintains Intratesticular Testosterone in Normal Men with Testosterone-Induced Gonadotropin Suppression. Journal of Clinical Endocrinology and Metabolism. 2005. Link
9. Walsh TJ, et al. Testosterone Therapy and Infertility. Urologic Clinics of North America. 2024. Link
10. AUA. Evaluation and Management of Testosterone Deficiency Guideline. 2024. Link
For men who are already azoospermic, HCG therapy drives sperm recovery in most cases within 4-6 months. Blood work is an imperfect guide. FSH levels that appear suppressed do not indicate treatment failure. Semen analysis is the only reliable way to track recovery.
The ExcelMale community has more than 20 years of practical experience navigating exactly these situations, including men who have successfully become fathers while remaining on testosterone throughout the process. Whether you are planning for children now or simply want to protect your options, the conversation with your prescriber about HCG should happen before your first injection, not after.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting or modifying any hormone therapy or medical treatment.
About ExcelMale.com
ExcelMale.com is the leading independent men's health forum with more than 24,000 members and a 20-year archive of peer-reviewed research, clinical discussions, and real-world patient experiences. The site was founded by Nelson Vergel, a chemical engineer, long-time TRT patient, and author of Testosterone: A Man's Guide and Beyond Testosterone. Nelson has been a patient advocate in men's health for over 30 years and brings a uniquely evidence-driven, community-oriented perspective to hormone optimization education.
| Key Takeaways |
| • Exogenous testosterone shuts down LH and FSH within weeks, causing azoospermia in the majority of men by 10 weeks. • HCG acts as an LH mimic, maintaining intratesticular testosterone (ITT) and preserving sperm production even when the pituitary is suppressed. • When used preventively alongside TRT, 1,500 IU of HCG weekly reduces azoospermia risk from 81% to just 7%. • FSH blood levels are poor predictors of actual sperm counts. Men with suppressed FSH can still have millions of motile sperm. • HCG monotherapy is often sufficient for restoring fertility; adding clomiphene does not consistently improve sperm output. • Recovery timelines average 4-6 months, but sperm can return even when gonadotropin labs remain below normal range. |
You started testosterone therapy to feel better. More energy, clearer thinking, stronger in the gym. It worked. But at some point, the question of fatherhood comes up, and you discover that TRT has been quietly doing something you weren't told about: it has likely shut off your sperm production entirely.
This is one of the most common and consequential gaps in TRT counseling. According to a survey of specialists from the Society for the Study of Male Reproduction (SSMR), nearly 46% of men starting TRT had no idea the therapy could render them infertile. For men who decide they want children, this moment of discovery is a crisis. The good news is that restoring, and often preserving, sperm production is possible with targeted therapy. The primary tool is human chorionic gonadotropin (HCG).
This guide explains exactly how TRT suppresses your reproductive system, how HCG counteracts that suppression, what the clinical data actually shows about recovery timelines, and how to interpret blood work that may be telling you the wrong story.
Why Does Testosterone Therapy Switch Off Sperm Production?
The answer lies in the Hypothalamic-Pituitary-Gonadal (HPG) axis, the brain-to-testes communication chain that regulates both testosterone levels and sperm output. Under normal conditions, the hypothalamus sends a pulsatile signal (GnRH) to the pituitary gland, which then releases two hormones essential to male reproductive function:• Luteinizing Hormone (LH): tells the Leydig cells in the testes to produce testosterone.
• Follicle Stimulating Hormone (FSH): tells the Sertoli cells to initiate and sustain spermatogenesis.
When you inject or apply exogenous testosterone, your brain detects elevated circulating levels and applies the brakes on the entire axis. The hypothalamus reduces GnRH output. The pituitary stops releasing LH and FSH. Without LH signaling, the testes' Leydig cells stop producing intratesticular testosterone (ITT), the high-concentration testosterone inside the testicular tissue itself that drives sperm maturation. ITT can be 50 to 100 times higher than serum testosterone under normal conditions. When exogenous testosterone replaces that signal, ITT can drop by up to 94% from baseline.
Without adequate ITT and FSH, the spermatogenic machinery stalls. Studies show that clinical azoospermia (zero sperm in ejaculate) can develop within 10 weeks of starting TRT at doses of 100-200 mg per week. One landmark WHO study found that after 6 months of 200 mg/week testosterone enanthate, 65% of men were fully azoospermic, with the remainder severely oligospermic. Up to 10% of men may remain azoospermic for an extended period even after stopping TRT, without intervention.
How Does HCG Bypass the Suppressed HPG Axis?
HCG is a naturally occurring hormone produced during pregnancy that is structurally and functionally similar to LH. When administered to men on TRT, it bypasses the suppressed pituitary entirely and acts directly on testicular Leydig cells, stimulating them to produce ITT. This keeps the testicular environment viable for sperm production even when the brain has stopped sending the signal.Think of HCG as a bypass cable that connects power directly to the engine when the ignition switch is off. The pituitary may be quiet, but the testes receive the signal they need to keep running.
What HCG Does Not Do: The FSH Gap
An important limitation: HCG primarily mimics LH, not FSH. In some men, FSH stimulation of Sertoli cells is necessary for full spermatogenic recovery. This is why, in cases where HCG alone is insufficient, exogenous FSH or hMG (human menopausal gonadotropin) is added to a recovery protocol. However, as the data below shows, most men produce meaningful sperm counts without ever normalizing their FSH blood levels.What Does the HPG Axis Response to HCG Actually Look Like?
A critical study by Kannady et al. (presented at AUA, reviewed in Fertility and Sterility) followed 59 men with TRT-induced azoospermia who underwent HCG therapy. The findings challenge the assumption that normalized blood work is required for fertility recovery.| Time Point | Men Evaluated | LH Still Suppressed | FSH Still Suppressed |
| 1 Month | 45 | 24 (53%) | 22 (49%) |
| 3 Months | 41 | 25 (61%) | 20 (49%) |
| 6 Months | 15 | 8 (53%) | 8 (53%) |
The striking finding: at every time point, roughly half of men on HCG still had suppressed LH and FSH below the 1.5 mIU/mL recovery threshold. By the traditional interpretation, these men should not be producing viable sperm. But that is not what semen analysis showed.
Why Your Blood Work May Be Misleading You
When researchers compared Total Motile Sperm (TMS) counts between men whose FSH recovered and those who remained suppressed, the results were counterintuitive:| Time Point | Suppressed FSH Mean TMS | Recovered FSH Mean TMS | P-Value |
| 3 Months | 33.48 million | 44.65 million | 0.57 (not significant) |
| 6 Months | 33.68 million | 23.69 million | 0.55 (not significant) |
At 3 months, there was no meaningful difference between groups. At 6 months, the suppressed FSH group actually had higher average sperm counts than the recovered group. These results carry a clear clinical message: when managing TRT-induced infertility, semen analysis is a more reliable guide than serum gonadotropins. Do not delay fertility decisions because FSH has not crossed a lab threshold.
Is It Better to Prevent Azoospermia or Treat It After the Fact?
The answer from recent data is decisive: prevention is far superior to restoration. A study by Oppenheimer et al. examined men with proven prior fertility who were starting TRT at doses of 200-300 mg per week. Half received TRT alone; the other half received TRT combined with 1,500 IU of HCG once weekly. The outcomes separated dramatically:| Outcome | TRT Only | T TRT+ HCG (1,500 IU/week) |
| Azoospermia Rate | 81% | 7% |
| Median Total Motile Count | 0 million | 13.7 million |
| Men Below 5M TMC Threshold | 100% | Minority |
A multivariate regression confirmed that HCG use was the only statistically significant predictor of higher sperm counts (p < 0.0001). Patient age and duration of prior TRT were not significant factors. This is reassuring: the protective effect of prophylactic HCG holds regardless of how old you are or how long you have been on testosterone, as long as HCG is started alongside TRT.
How Does HCG Monotherapy Compare to HCG Plus Clomiphene for Restoration?
When TRT-induced azoospermia has already occurred, the standard recovery protocol involves discontinuing TRT and starting HCG. Many clinicians add clomiphene citrate (a SERM) to stimulate the pituitary to produce its own FSH. The rationale is sound in theory, but the data from Walia et al. tells a different story.In 42 men with TRT-induced azoospermia (median 19.5 months on TRT), combination therapy (HCG + clomiphene, n = 33) was compared to HCG monotherapy alone (n = 9):
| Metric | HCG Monotherapy | HCG + Clomiphene | P-Value |
| Median Total Motile Count | 7.65 million | 13.5 million | 0.348 (not significant) |
| FSH Recovery (suppressed group) | 37.5% | 50% | 0.693 (not significant) |
The difference in sperm output between the two regimens was not statistically significant. Adding clomiphene produced a non-significant trend toward better FSH normalization but did not meaningfully increase the number of motile sperm produced. Given that FSH normalization does not correlate reliably with sperm count anyway, this finding reinforces HCG monotherapy as a rational, sufficient, and more cost-effective first-line approach for most men.
A 2024 study in Fertility and Sterility using a 3,000 IU hCG + 75 IU FSH three-times-weekly protocol in 77 men showed that 74% improved sperm concentration. Importantly, men who stayed on testosterone therapy during the recovery protocol had identical recovery rates (74%) to those who stopped TRT, suggesting that you may not always need to discontinue testosterone to restore fertility.
What Is the Typical Recovery Timeline After Starting HCG?
Recovery does not happen overnight, and it is not linear. Based on current data from multiple cohorts:• First 1-3 months: Most men see initial sperm return. In Kannady et al., 89% of men demonstrated the return of spermatogenesis within the first 3 months of HCG treatment. Average time to first semen analysis showing sperm was 4.6 months.
• 3-6 months: Parameters continue to improve. Some men with prolonged suppression or older age take longer to optimize counts and motility.
• 6-12 months: Men on TRT for more than one year, or those over age 60, may require up to 12 months or longer. Approximately 56% of specialists consider recovery unlikely after more than one year of TRT, though recent data challenges this pessimism.
• Persistent azoospermia: Up to 10-20% of men do not recover normal spermatogenesis without pharmacological support, even after stopping TRT.
The ExcelMale community has documented many men who successfully restored fertility after years on TRT, in some cases while staying on testosterone throughout the process. The ExcelMale thread on improving sperm quality, LH, FSH and testosterone in infertile men includes first-hand accounts from men who achieved pregnancy without ever stopping TRT, using combined HCG and FSH protocols.
What HCG Dosing Protocols Do Clinicians Use?
There is no universal consensus on dosing, which reflects both the complexity of individual response and the current lack of formal clinical guidelines. The SSMR survey found high variability among specialists, with doses ranging from 500 IU to 5,000 IU per treatment.| Clinical Goal | Typical HCG Protocol | Notes |
| Fertility preservation (on TRT) | 1,500 IU once weekly | Oppenheimer et al. data; reduces azoospermia to 7% |
| Low-dose preservation (on TRT) | 250-500 IU every other day | Hsieh/Coviello data; maintains normal sperm parameters |
| Restoration after TRT cessation | 2,000-3,000 IU 3x/week (MWF) | Most common specialist protocol; 44% use 2,000 IU 3x/wk |
| Combined hCG/FSH reboot | 3,000 IU hCG + 75 IU FSH 3x/wk | 2024 Fertility and Sterility; 74% improved in 77 men |
Dose escalation is commonly used. In the SSMR survey, 76% of providers reported escalating HCG dose when initial response was insufficient. The need for dose adjustment underscores the importance of serial semen analysis rather than relying solely on lab work to guide decisions.
What Are the Real-World Barriers to Getting Proper Fertility Care on TRT?
Beyond the biology, there are practical and financial obstacles that many men in our community encounter:• Insurance coverage: 80% of SSMR specialists report that insurance rarely covers HCG fertility treatments. For men paying out of pocket, a 2,000 IU three-times-weekly protocol can be a significant ongoing expense.
• Provider knowledge gaps: Many primary care physicians and even some TRT prescribers are not adequately informed about fertility preservation. Some men have been told HCG is only cosmetic. This is incorrect.
• Lack of standardized guidelines: There is currently no published consensus protocol from major urology or endocrinology societies for TRT-induced infertility beyond the broad recommendation to stop TRT. Dosing, timing, and monitoring decisions vary widely by provider.
• Delayed counseling: With 46% of men starting TRT unaware of fertility risk, many do not begin preservation strategies in time. Sperm banking before starting TRT is an option that is underutilized.
If you are facing insurance denials, the ExcelMale forum has threads discussing compounding pharmacy options for HCG and strategies for working with fertility specialists who understand TRT-related cases.
Frequently Asked Questions
Can I stay on testosterone while taking HCG to restore fertility?
For preservation, yes. Research, including the 2024 Fertility and Sterility hCG/FSH study, shows that concurrent testosterone therapy does not impair spermatogenic recovery compared to stopping TRT. Some men successfully restore fertility while remaining on their testosterone protocol. That said, some fertility specialists will recommend TRT cessation, so it is worth discussing this question explicitly with a provider familiar with this patient population.How do I know if HCG is working if my FSH blood test is still low?
Get a semen analysis, not just blood work. As the Kannady data shows, suppressed FSH does not reliably predict sperm counts. Men with FSH below 1.5 mIU/mL can have tens of millions of motile sperm. A semen analysis at 3 months is a far better indicator of HCG efficacy than a gonadotropin panel.What if HCG alone does not restore my sperm count?
If HCG monotherapy is insufficient after 3-6 months, the next step is typically adding FSH or hMG to the protocol. HCG stimulates Leydig cells and ITT production, while FSH directly supports Sertoli cell function, which is the other half of the spermatogenic equation. This combination targets both pathways and is supported by the 2024 hCG/FSH reboot data showing 74% improvement in sperm concentration.Should I bank sperm before starting TRT?
If there is any chance you will want biological children in the future, sperm banking before starting TRT is a low-cost insurance policy. The procedure is straightforward, samples can be stored for many years, and it removes any time pressure from fertility recovery later. This option is consistently underutilized and undersold in standard TRT consultations.Does the length of time on TRT affect my chances of recovery?
Duration of TRT use does influence recovery, but not as decisively as once thought. The Oppenheimer preservation data found that age and TRT duration were not statistically significant when HCG was used alongside testosterone. For restorative cases, longer TRT duration and older age (over 60) are associated with slower and less complete recovery. Sperm banking before TRT remains the most reliable mitigation for men planning future families.Is it normal for my testicles to shrink on TRT, and does HCG reverse that?
Yes, testicular atrophy is a common effect of TRT-induced HPG suppression. HCG, by providing LH-like stimulation to the testes, typically reverses testicular volume loss and maintains the internal testicular environment. Many men report that this is the primary cosmetic and functional reason they add HCG to their TRT protocol, independent of fertility goals.Related ExcelMale Forum Discussions
• HCG use with testosterone to improve fertility, libido, and testicular size (comprehensive multi-part series)• Why use HCG with TRT? A clinical review covering HPG mechanisms and dosing evidence
• Best HCG dose for men on TRT: landmark studies reviewed
• HCG dose and frequency for fertility and testicular atrophy prevention
• HCG dosage strategies for TRT optimization
• Recovery of sperm production following testosterone replacement or anabolic steroids
• Testosterone as a contraceptive: what men who want fertility need to know
• How long before LH and FSH shut down after starting testosterone?
• Fertility maintenance or restoration in men before, during, and after TRT or AAS
• Improving sperm quality, LH, FSH and testosterone in infertile men: community experiences
Key References
1. Kannady C, et al. HPG Axis Response to HCG Treatment After Testosterone-Induced Infertility. Fertility and Sterility. 2024. Link2. Fertility and Sterility. Optimal Restoration of Spermatogenesis After Testosterone Therapy Using HCG and FSH. 2024. Link
3. Hochu G, Geyer-Kim I, Kim E. Preserving Spermatogenesis in Testosterone Deficiency: Innovations in Replacement and Stimulatory Therapies. Translational Andrology and Urology. 2025. Link
4. PMC. Clinician's Guide to Management of Azoospermia Induced by Exogenous Testosterone or AAS. 2025. Link
5. McBride JA, Coward RM. Recovery of Spermatogenesis Following Testosterone Replacement Therapy or Anabolic-Androgenic Steroid Use. Asian Journal of Andrology. 2016. Link
6. Kohn TP, et al. Fertility Outcomes After Testosterone Replacement Therapy or Anabolic Steroid Abuse. Journal of Urology. 2018. Link
7. Hsieh TC, et al. Concomitant Intramuscular Human Chorionic Gonadotropin Preserves Spermatogenesis in Men Undergoing Testosterone Replacement Therapy. Journal of Urology. 2013. Link
8. Coviello AD, et al. Low-Dose Human Chorionic Gonadotropin Maintains Intratesticular Testosterone in Normal Men with Testosterone-Induced Gonadotropin Suppression. Journal of Clinical Endocrinology and Metabolism. 2005. Link
9. Walsh TJ, et al. Testosterone Therapy and Infertility. Urologic Clinics of North America. 2024. Link
10. AUA. Evaluation and Management of Testosterone Deficiency Guideline. 2024. Link
Conclusion: What Every Man on TRT Should Know
TRT-induced azoospermia is common, predictable, and in most cases reversible, but it requires proactive management. The single most effective strategy is adding HCG prophylactically at the start of TRT, before sperm suppression occurs. The data is clear: 1,500 IU once weekly reduces azoospermia risk from 81% to 7%.For men who are already azoospermic, HCG therapy drives sperm recovery in most cases within 4-6 months. Blood work is an imperfect guide. FSH levels that appear suppressed do not indicate treatment failure. Semen analysis is the only reliable way to track recovery.
The ExcelMale community has more than 20 years of practical experience navigating exactly these situations, including men who have successfully become fathers while remaining on testosterone throughout the process. Whether you are planning for children now or simply want to protect your options, the conversation with your prescriber about HCG should happen before your first injection, not after.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting or modifying any hormone therapy or medical treatment.
About ExcelMale.com
ExcelMale.com is the leading independent men's health forum with more than 24,000 members and a 20-year archive of peer-reviewed research, clinical discussions, and real-world patient experiences. The site was founded by Nelson Vergel, a chemical engineer, long-time TRT patient, and author of Testosterone: A Man's Guide and Beyond Testosterone. Nelson has been a patient advocate in men's health for over 30 years and brings a uniquely evidence-driven, community-oriented perspective to hormone optimization education.
Last edited:
